Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jun
15
2017
En Banc Opinion Could Set Precedent for Tied-House Laws McDermott Will & Emery
Aug
7
2017
FDA Outlines New Digital Health Innovation Action Plan and Software Precertification Pilot Program McDermott Will & Emery
Jul
1
2010
The 50% Tax Credit / Cash Grant for Life Sciences Companies Troutman Pepper
Jul
14
2020
Is a Wave of PFAS Consumer Class Actions on the Horizon? Hunton Andrews Kurth
Jan
10
2024
EU Corporate Sustainability Due Diligence Directive Nearly Final Hunton Andrews Kurth
Feb
9
2024
Finalizing PFAS Detection Methods, EPA Moves Closer to Locating and Limiting Further PFAS Releases and Requiring Their Cleanup Hunton Andrews Kurth
Apr
1
2024
Recent Delaware Coverage Decisions on Relatedness Leaves D&O Claim Uncertainties Hunton Andrews Kurth
Apr
21
2017
PTAB's Finding of Obviousness Upheld Despite that Prior District Court Found the Claims Non-Obvious Hunton Andrews Kurth
Jun
10
2020
Virginia Enacts “Ban the Box” Legislation for Marijuana Possession Arrests, Charges, and Convictions Hunton Andrews Kurth
Apr
21
2017
Summary Judgment of Patent Infringement is Vacated Because the Defendant’s ANDA Did Not Meet the “Efficient Mixing” of the Asserted Claims Hunton Andrews Kurth
Oct
26
2017
Appeal of Discovery Order in BPCIA Patent Infringement Case Dismissed for Lack of Jurisdiction and Writ of Mandamus for Compelling Discovery Denied Hunton Andrews Kurth
Sep
9
2021
Recall Roundup: August 2021 Hunton Andrews Kurth
Feb
14
2022
Philadelphia and Montana Join List of Jurisdictions That Provide Protections for Recreational Marijuana Use Hunton Andrews Kurth
Jun
8
2023
Minnesota Becomes Second State To Pass Sweeping PFAS Ban and Reporting Law Targeting All Products Hunton Andrews Kurth
Oct
26
2017
R&H’s Processes for Preparing Emulsion Polymers with Improved Opacity Not Invalid over the Prior Art that Does Not Include a “Swelling Agent” Narrowly Construed by the PTAB Hunton Andrews Kurth
May
20
2021
The Trend Towards Legal Recreational Cannabis: Considerations for Employers Hunton Andrews Kurth
Oct
6
2022
New California Legislation Protects Workers’ Personal Marijuana Use Hunton Andrews Kurth
Jun
5
2020
HHS Rule is Good News for Prescription Drug Accumulator Programs Hunton Andrews Kurth
Nov
12
2020
Divided FTC Finalizes “No-Fault, No-Money Settlement” Agreement with Skincare Brand, Sunday Riley Hunton Andrews Kurth
May
3
2024
Congress Extends Statute of Limitations for Sanctions Violations Hunton Andrews Kurth
Jul
31
2017
Chemical Compound Invention, Even if the Inherent Result of a Well-Known Process, is not Obvious if there is no Teaching or Suggestion to Make the Compound in the Prior Art Hunton Andrews Kurth
Apr
13
2021
Recall Roundup: March Hunton Andrews Kurth
Jul
11
2012
Patent Trends (or Lack thereof) in Green Energy Technology Hunton Andrews Kurth
Mar
27
2014
Revocation – An Effective Remedy for a Breach of Licence Obligations? Hunton Andrews Kurth
Sep
6
2022
Seller Beware—Considering How Walgreens’ Liability for the San Francisco Opioid Epidemic Applies to Retail Pharmacies Everywhere Hunton Andrews Kurth
Jan
26
2023
Do the Products You Sell Contain PFAS? Hunton Andrews Kurth
Apr
3
2023
EPA Proposes National Primary Drinking Water Regulation to Set Stringent Limits on PFAS in Drinking Water, Including Four Newly Targeted Substances Hunton Andrews Kurth
Aug
24
2020
Reading the Leaves: Financing Trends in the Cannabis Industry Hunton Andrews Kurth
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins